Valsartan Tablet, Film Coated
Product Images NDC 82868-011

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 82868-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (82868 011 30 Rev A 08 23)

Label for Valsartan 160 mg film-coated tablets, USP. The carton contains 30 tablets for oral use. The label includes storage instructions, dosage note to see package insert, and legal status as prescription only. Manufactured by Ascend Laboratories, LLC and repackaged by Northwind Pharmaceuticals.*

FDA Label Image

Val-struct (Val Struc)

Chemical structure diagram of valsartan, the active ingredient.*

FDA Label Image

Val-chart-1 (Val Chart 1)

A forest plot chart comparing Valsartan versus Captopril across various patient subgroups. The subgroups include age (<65 years, ≥65 years), gender (male, female), race (Caucasian, Non-Caucasian), geographic location (US, Non-US), and Beta-blocker use (Yes, No). Each subgroup has a corresponding dot with confidence intervals indicating the comparative favoring of Valsartan or Captopril.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.